Guiding principles

		1. Manufacturing location in Germany Our group of companies looks back at over 50 years of experience in precision technology. Today we are a "global player" with German... |continue|
		2. The patient is in the centre Concern for health is our major asset. Since we are conscious of this, we are investing as a successful medical company in the future of ocular implants. We ... |continue|
		3. Growth is our objective During the past few years HumanOptics AG has grown constantly. We consider this growth to be a challenge, also to develop and manufacture in the future first class ... |continue|
		4. Research & development Innovative products are necessary for continuous growth and the development of new markets. For this reason we are investing a substantial ... |continue|
		5. We remain independent The HumanOptics Group is an independent; researching and manufacturing medical technology company and intends to remain so. Growth is achieved ... |continue|
		6. We consider us to be a partner of the doctor The group of companies has more than 50 years of experience in ophthalmology. The operator, his team and the patients are at HumanOptics AG in the centre stage ... |continue|
		7. Intensive exchange with science Today HumanOptics AG is internationally one of the most research active manufacturers of eye implants. The HumanOptics Group creates value through ... |continue|
		8. We offer proven quality We are obliged to satisfy our customers and shareholders with the quality of our products and services. Through regular ... |continue|
		9. Sustainability and economy A sustainable increase in the value of our company requires long term planning and action. The success criteria for this are innovative products and ... |continue|

 1. We believe in the manufacturing location in Germany

Our group of companies looks back at over 50 years of experience in precision technology. Today we are a "global player" with German roots. We manufacture at our production facilities in Erlangen and St. Augustin intraocular implants at the very highest technological level. In this respect we are both socially and ecologically responsible. Security of the workplace and protection of the environment together with the quality of our intraocular lenses are the major centre of our attention.
back to top
 2. The patient is in the centre

Concern for health is our major asset. Since we are conscious of this, we are investing as a successful medical company in the future of ocular implants. We develop and manufacture innovative intraocular lenses of the highest medical quality, in order to assure that people with ocular diseases such as e.g. cataract and cornea irregularities will regain the best sight possible and to restore their quality of life in the longer term. We consider ourselves to be committed to this objective also in the future. We also know that the value of a company does not only depend on sales figures but above all also on its good reputation and its credibility.

back to top
 3. Growth is our objective

During the past few years HumanOptics AG has grown constantly. We consider this growth to be a challenge, also to develop and manufacture in the future first class products as well as to run our business circumspectly. The confidence of our customers, business partners, shareholders, the authorities and the public in the responsible behaviour of all the employees of our group of companies is decisive for the success and image of our company.
back to top
 4. Research & development

Innovative products are necessary for continuous growth and the development of new markets. For this reason we are investing a substantial part of our profit in research and development. HumanOptics has also set itself the task to develop new types of innovative eye implants, which represent a substantial contribution to the quality of life of the patient.

In this respect all necessary technologies are taken into consideration, which make the research and development processes the most efficient and productive possible.

The worldwide research competence of HumanOptics is complemented through a network of external partners (cooperation with other companies, universities and scientific organisations).

back to top
 5. We remain independent

The HumanOptics Group is an independent; researching and manufacturing medical technology company and intends to remain so. Growth is achieved to a large extent from its own funds, but cooperation and acquisitions are also the basis for our positive results. HumanOptics is extending its activities further with its three facilities in Erlangen, Mannheim and St. Augustin. Our independence makes us flexible and helps us to react quickly to the requirements of our customers.

In order to achieve the targeted sales and profit growth, we exploit the opportunities of globalisation and shall continuously expand our foreign business.
back to top
 6. We consider us to be a partner of the doctor

The group of companies has more than 50 years of experience in ophthalmology. The operator, his team and the patients are in the centre stage at HumanOptics. In close cooperation with the doctors we recognise which products are required. As a result we develop and manufacture eye implants, which are exactly tailor-made for the current requirements.
back to top
 7 . Intensive exchange with science

Today HumanOptics AG is internationally one of the most research active manufacturers of eye implants. The HumanOptics Group creates value through innovation. Products and services change at increasingly shorter intervals in a highly competitive environment. In order to continue to be successful a manufacturer of medical products must be superior to his competitors and permanently impress the market with innovative solutions. We are working continuously at the realisation of our creative ideas. In this respect particular emphasis is laid on the development of progressive "intelligent" intraocular lenses.
back to top
 8. We offer proven quality

We are obliged to satisfy our customers and shareholders with the quality of our products and services. Through regular customer interviews we know the requirements of the market very well and can react promptly to new trends. We integrate the most modern technologies into our work processes for optimisation and quality control. We cooperate closely with scientific institutes, universities and opinion makers at an international level.

We consider as our core task the assuring of the quality of our implants. We achieve this through a functioning quality control management and the active support of all our employees. We monitor our management system regularly and have this confirmed with ISO certificates by external parties. HumanOptics is certified in accordance with DIN EN ISO 13485:2003 and DIN EN ISO 9001:2000.

back to top
 9. Sustainability and economy

A sustainable increase in the value of our company requires long term planning and action. The success criteria for this are innovative products and services, increasing profitability, fair market returns as well as secure workplaces. We intend to increase sales and profit in excess of the market average, so that the HumanOptics share remains attractive as a long term investment.

As a progressive medical technology company we know that we bear a particular responsibility towards human beings and nature when we bring innovations to market maturity. Our highest priorities are safety and health at the workplace, environment-friendly production processes and an open dialogue with scientists, customers and the public. We consider environment-friendly action not only to be our duty but also as a prerequisite for maintaining our competitiveness and our market value.

The relationship with our competitors is characterised by fairness, since we observe the regulations valid for the market.